Hung Wei-En, Chou Wen-Chi, Chen Chen Hsiu, Tang Siew Tzuh
School of Nursing, Medical College, Chang Gung University, Tao-Yuan, Taiwan, ROC; Department of Nursing, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Taiwan, ROC.
Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Tao-Yuan, Taiwan, ROC; College of Medicine, Chang Gung University, Tao-Yuan, Taiwan, ROC.
Intensive Crit Care Nurs. 2025 Apr 29;89:104055. doi: 10.1016/j.iccn.2025.104055.
Few studies comprehensively investigate factors associated with significant post-traumatic-stress-disorder (PTSD) symptoms among family members of ICU decedents. We aimed to identify factors associated with significant PTSD symptoms among bereaved ICU family members, focusing on those modifiable through high-quality end-of-life ICU care.
A cohort study of 321 bereaved family members of critically ill patients assessed PTSD symptoms at 1, 3, 6, 13, 18, and 24 months postloss using the Impact of Event Scale-Revised (IES-R). Family-rated quality of dying and death (QODD) and ICU care satisfaction were assessed 1 month postloss using the ICU-QODD and Family Satisfaction in the ICU (FS-ICU) scales, respectively. Multivariable logistic regression with generalized estimating equations examined associations between significant PTSD symptoms and intrapersonal (demographics, vulnerabilities), interpersonal (perceived social support measured by the Medical Outcome Study Social Support Survey), bereavement-related (patient demographics, clinical characteristics), and death-circumstance (ICU-QODD and FS-ICU scores) factors identified from significant univariate analyses.
Prevalence of significant PTSD symptoms decreased substantially over time (from 11.0 % at 1 month to 0 % at 24 months post loss). Financial insufficiency (adjusted odds ratio [AOR][95 % CI] = 3.281[1.306, 8.244]) and use of antidepressants in the year prior to the patient's critical illness (AOR[95 % CI] = 6.406 [1.868, 21.967]) increased the likelihood of significant PTSD symptoms. Stronger family-perceived social support (AOR[95 % CI] = 0.964 [0.941, 0.988]) and higher family-judged patient QODD in ICUs (AOR[95 % CI] = 0.632 [0.435, 0.918]) lowered the odds of significant PTSD symptoms.
Modifiable end-of-life ICU care factors, i.e. higher family-judged patient QODD and family-perceived social support, reduced bereaved ICU family members' likelihood of significant PTSD symptoms.
To reduce the likelihood of significant PTSD symptoms in bereaved family members, ICU clinicians should provide high-quality end-of-life care to improve patient QODD and leverage social support, particularly for at-risk groups with financial challenges or prior antidepressant use.
很少有研究全面调查重症监护病房(ICU)死亡患者家属中与创伤后应激障碍(PTSD)显著症状相关的因素。我们旨在确定ICU丧亲家属中与PTSD显著症状相关的因素,重点关注那些可通过高质量的ICU临终关怀加以改变的因素。
对321名重症患者的丧亲家属进行队列研究,在丧亲后1、3、6、13、18和24个月使用事件影响量表修订版(IES-R)评估PTSD症状。分别在丧亲后1个月使用ICU临终关怀与死亡质量量表(ICU-QODD)和ICU家庭满意度量表(FS-ICU)评估家庭评定的死亡质量和ICU护理满意度。使用广义估计方程的多变量逻辑回归分析了PTSD显著症状与单因素分析中确定的个人因素(人口统计学、易感性)、人际因素(通过医学结局研究社会支持调查测量的感知社会支持)、丧亲相关因素(患者人口统计学、临床特征)以及死亡情况(ICU-QODD和FS-ICU评分)之间的关联。
PTSD显著症状的患病率随时间大幅下降(从丧亲后1个月的11.0%降至24个月时的0%)。经济不足(调整优势比[AOR][95%置信区间]=3.281[1.306, 8.244])以及患者重病前一年使用抗抑郁药(AOR[95%置信区间]=6.406 [1.868, 21.967])增加了出现PTSD显著症状的可能性。更强的家庭感知社会支持(AOR[95%置信区间]=0.964 [0.941, 0.988])以及家庭评定的ICU患者临终关怀质量更高(AOR[95%置信区间]=0.632 [0.435, 0.918])降低了出现PTSD显著症状的几率。
可改变的ICU临终关怀因素,即更高的家庭评定患者临终关怀质量和家庭感知社会支持,降低了ICU丧亲家属出现PTSD显著症状的可能性。
为降低丧亲家属出现PTSD显著症状的可能性,ICU临床医生应提供高质量的临终关怀以改善患者临终关怀质量并利用社会支持,特别是对于有经济困难或之前使用过抗抑郁药的高危人群。